Print
Text Size
ULTRABAC® 7/SOMUBAC®
Clostridium Chauvoei-Septicum-Novyi-Sordellii-Perfringens Types C and D Haemophilus Somnus Bacterin-Toxoid
For use in healthy cattle and calves three months of age or older as an aid in preventing blackleg caused by Clostridium chauvoei, malignant edema caused by Cl. septicum, black disease caused by Cl. novyi, gas-gangrene caused by Cl. sordellii, enterotoxemia and enteritis caused by Cl. perfringens Types B, C and D, and disease caused by Histophilus somni (Haemophilus somnus). Although Cl. perfringens Type B is not a significant problem in North America, immunity is provided by the beta toxoid of Type C and the epsilon toxoid of Type D. Ultrabac 7/Somubac consists of killed, standardized cultures of Cl. chauvoei, Cl. septicum, Cl. novyi, Cl. sordellii, Cl. perfringens Types C and D, and H. somni, with an adjuvant.
Collapse All
-
Uses
Aids in the prevention of diseases caused by the clostridial agents indicated above and Histophilus somni (Haemophilus somnus).
Key Features
- Helps prevent seven clostridial diseases (including diseases caused by CI. perfringens Types B, C and D), which continue to be of economic importance in cattle. Clostridium bacteria are universally present and produce potent toxins that can result in rapid death of otherwise healthy animals.
- Helps protect calves and adult cattle against H. somni, a contributor to respiratory disease and the cause of thrombotic meningoencephalitis (TEME) and reproductive tract infection.
- Subcutaneous (SC) dose is 5 mL, followed by a second dose given four to six weeks later. Annual revaccination with a single dose is recommended.
-
Precautions
Store at 2°-7°C. Do not freeze. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.
